Watchdog outs Medicaid-funded autism provider with history of abuse cases
A private equity-owned autism therapy chain that receives Medicaid payments is facing scrutiny over allegations of improper billing and child abuse, according to a new watchdog report.
TL;DR
- Hopebridge, a private equity-owned autism therapy chain, is under scrutiny for alleged improper billing and child abuse.
- A watchdog report by the American Accountability Foundation (AAF) claims Hopebridge's business model prioritizes investor returns over patient care.
- Allegations include submitting claims for non-individualized care plans and instances of alleged child abuse and inadequate supervision.
- Hopebridge has faced legal settlements regarding billing practices and employee wage disputes.
- The company denies the allegations, emphasizing its service to over 11,700 families and millions of therapy hours.
- Increased government scrutiny on Medicaid-funded autism services and potential fraud is noted.